Zambon to acquire 9.1% stake in Newron Pharmaceuticals - MarketLine Financial Deals

Zambon to acquire 9.1% stake in Newron Pharmaceuticals

Zambon to acquire 9.1% stake in Newron Pharmaceuticals - MarketLine Financial Deals
Zambon to acquire 9.1% stake in Newron Pharmaceuticals
Published Apr 05, 2012
3 pages — Published Apr 05, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Zambon Company S.p.A., a pharmaceutical and chemical company, has agreed to make a EUR20 million equity investment in Newron Pharmaceuticals S.p.A.

  
Source:
Document ID
MA104475_120409
Country
Ticker
NWRN=IT
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Zambon to acquire 9.1% stake in Newron Pharmaceuticals" Apr 05, 2012. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Zambon-to-acquire-9-1-stake-in-Newron-Pharmaceuticals-2052-79815>
  
APA:
MarketLine Financial Deals. (2012). Zambon to acquire 9.1% stake in Newron Pharmaceuticals Apr 05, 2012. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Zambon-to-acquire-9-1-stake-in-Newron-Pharmaceuticals-2052-79815>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.